AbbVie Inc. Stock Falls Wednesday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) slipped 0.69% to $106.41 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.95% to 4,395.64 and the Dow Jones Industrial Average rising 1.00% to 34,258.32. AbbVie Inc. closed $15.12 short of its 52-week high ($121.53), which the company achieved on September 1st.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Pfizer Inc. (PFE) rose 0.07% to $43.95, Eli Lilly & Co. (LLY) fell 0.81% to $228.30, and AstraZeneca PLC ADR (AZN.LN) fell 0.66% to $58.74. Trading volume (6.3 M) remained 856,834 below its 50-day average volume of 7.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 22, 2021.
(END) Dow Jones Newswires
September 22, 2021 16:33 ET (20:33 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.